ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Barcelona, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Coronavirus Infections
Infections
Post-Acute COVID-19 Syndrome
Human Influenza
Pneumonia
Virus Diseases
Communicable Diseases

COVID-19 trials near Barcelona, CT, ESP:

Locations recently updated

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

IV compared to remdesivir IV alone for the treatment of symptomatic COVID-19 in severely immunocompromised adult participants who a...

Enrolling
COVID-19 Infection
Drug: remdesivir
Drug: placebo for ibuzatrelvir

Phase 3

Pfizer
Pfizer

Barcelona, Barcelona [barcelona], Spain and 61 other locations

The study aims to prove that plitidepsin could be an efficacious, safe, and well-tolerated therapy for PCC. To this end, we will perform a randomized...

Enrolling
Post COVID-19 Condition
Persistent COVID-19
Drug: Placebo and Plitidepsin 1.5mg/day
Drug: Plitidepsin 1.5 mg/day

Phase 2

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

Badalona, Barcelona, Spain

Since the start of the COVID-19 pandemic, the approach to solid organ transplantation has evolved. Transplants using organs (exclud-...

Enrolling
COVID - 19
SARS CoV 2 Infection
Drug: Remdesivir (RDV)

Phase 2

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

Badalona, Barcelona, Spain

Locations recently updated

The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...

Enrolling
COVID-19 SARS-CoV-2 Infection
Drug: placebo
Drug: ibuzatrelvir

Phase 3

Pfizer
Pfizer

Barcelona, Barcelona [barcelona], Spain and 208 other locations

Locations recently updated

Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...

Enrolling
Coronavirus Disease (COVID-19)
Drug: Placebo
Drug: Molnupiravir

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Barcelona, Spain and 205 other locations

The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental...

Enrolling
Viral Lung Infection and Acute Respiratory Failure
Drug: Tozorakimab
Drug: Placebo

Phase 3

AstraZeneca
AstraZeneca

Barcelona, Spain and 446 other locations

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...

Active, not recruiting
Early Alzheimer's Disease
Drug: Lecanemab SC
Drug: Lecanemab IV

Phase 3

Eisai
Eisai

Barcelona, Spain and 246 other locations

) neo-antigen in subjects with relapsing multiple sclerosis (RMS).COVID-19 sub-study:The purpose of this research sub-study is to e...

Active, not recruiting
Relapsing Multiple Sclerosis
Biological: 23-valent pneumococcal polysaccharide vaccine (23-PPV)
Biological: Tetanus toxoid (TT) containing vaccine (Td, Tdap)

Phase 3

Novartis
Novartis

Barcelona, Catalonia, Spain and 299 other locations

Locations recently updated

treatment in Study M16-067 with no final endoscopy due to the Covid-19 pandemic or due to the geopolitical conflict in Ukraine and ...

Active, not recruiting
Ulcerative Colitis (UC)
Drug: placebo for risankizumab
Drug: risankizumab

Phase 3

AbbVie
AbbVie

Barcelona, Spain and 434 other locations

in Study M16-006 or Study M15-991 with no final endoscopy due to the Covid-19 pandemic. Additional objectives are to further invest...

Active, not recruiting
Crohn's Disease
Drug: Placebo for Risankizumab IV
Drug: Risankizumab SC

Phase 3

AbbVie
AbbVie

Barcelona, Spain and 499 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems